Balyasny Asset Management LLC Astrazeneca PLC Transaction History

Balyasny Asset Management LLC

$58 Billion
Q3 2024

A detailed history of Balyasny Asset Management LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Balyasny Asset Management LLC holds 9,500 shares of AZN stock, worth $633,080. This represents 0.0% of its overall portfolio holdings.

Number of Shares

9,500

Previous 720,003 98.68%

Holding current value

$633,080

Previous $56.2 Million 98.68%

% of portfolio

0.0%

Previous 0.1%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$76.67 - $87.62 $54.1 Million - $61.8 Million	-705,516 Reduced 97.99%	14,487 $1.13 Million
Q2 2024 Aug 14, 2024	BUY	$66.81 - $80.83 $23.3 Million - $28.2 Million	349,195 Added 94.17%	720,003 $56.2 Million
Q1 2024 May 13, 2024	BUY	$61.03 - $69.57 $22.6 Million - $25.8 Million	370,808 New	370,808 $25.1 Million
Q3 2023 Nov 14, 2023	SELL	$64.85 - $71.7 $19.2 Million - $21.2 Million	-296,107 Reduced 97.99%	6,070 $411,000
Q2 2023 Aug 14, 2023	BUY	$69.91 - $75.81 $21.1 Million - $22.9 Million	302,177 New	302,177 $21.6 Million
Q2 2022 Aug 15, 2022	BUY	$59.26 - $71.14 $29 Million - $34.8 Million	489,633 New	489,633 $32.4 Million
Q1 2022 May 16, 2022	SELL	$55.72 - $67.12 $11.2 Million - $13.5 Million	-201,198 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$54.02 - $63.83 $10.9 Million - $12.8 Million	201,198 New	201,198 $11.7 Million
Q1 2021 May 17, 2021	SELL	$47.16 - $54.44 $11.3 Million - $13 Million	-239,598 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$48.52 - $58.02 $11.6 Million - $13.9 Million	239,598 New	239,598 $12 Million
Q3 2020 Nov 16, 2020	SELL	$53.07 - $61.1 $51.2 Million - $59 Million	-965,697 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$43.1 - $55.31 $17 Million - $21.8 Million	394,950 Added 69.2%	965,697 $51.1 Million
Q1 2020 May 15, 2020	BUY	$37.79 - $51.33 $1.55 Million - $2.1 Million	40,998 Added 7.74%	570,747 $25.5 Million
Q4 2019 Feb 14, 2020	BUY	$42.46 - $50.46 $9.09 Million - $10.8 Million	214,134 Added 67.85%	529,749 $26.4 Million
Q3 2019 Nov 14, 2019	BUY	$40.12 - $45.47 $817,244 - $926,223	20,370 Added 6.9%	315,615 $14.1 Million
Q2 2019 Aug 14, 2019	BUY	$37.28 - $41.68 $7.98 Million - $8.92 Million	214,079 Added 263.75%	295,245 $12.2 Million
Q1 2019 May 15, 2019	SELL	$35.49 - $43.02 $20.1 Million - $24.4 Million	-566,567 Reduced 87.47%	81,166 $3.28 Million
Q4 2018 Feb 14, 2019	SELL	$36.86 - $41.49 $18.2 Million - $20.5 Million	-493,528 Reduced 43.24%	647,733 $24.6 Million
Q3 2018 Nov 14, 2018	BUY	$34.76 - $39.72 $2.57 Million - $2.94 Million	74,039 Added 6.94%	1,141,261 $45.2 Million
Q2 2018 Aug 14, 2018	BUY	$34.55 - $37.05 $3.42 Million - $3.67 Million	99,017 Added 10.23%	1,067,222 $37.5 Million
Q1 2018 May 15, 2018	BUY	$32.97 - $36.63 $514,760 - $571,904	15,613 Added 1.64%	968,205 $33.9 Million
Q4 2017 Feb 14, 2018	SELL	$32.09 - $34.78 $25.1 Million - $27.3 Million	-783,659 Reduced 45.14%	952,592 $33.1 Million
Q3 2017 Nov 14, 2017	BUY	$28.96 - $34.0 $50.3 Million - $59 Million	1,736,251	1,736,251 $58.8 Million

Others Institutions Holding AZN

# of Institutions

1,359

Shares Held

475M

Call Options Held

5.39M

Put Options Held

3.75M

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $207B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Balyasny Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Balyasny Asset Management LLC with notifications on news.

Account

Balyasny Asset Management LLC Astrazeneca PLC Transaction History